Archived Newsletters
-
08.06.25 -- Is Nanotechnology The Key To More Efficient Drug Development?
8/6/2025
08/06/25 Outsourced Pharma Newsletter
-
08.06.25 -- Relationship Equity With CDMOs Is Real, Take It From A Packaging Pro
8/6/2025
08/06/25 Outsourced Pharma Newsletter
-
08.05.25 -- Tech Transfer 2025 – A High-Stakes Game Of Trust
8/5/2025
08/05/25 Outsourced Pharma Newsletter
-
08.04.25 -- Meeting The Demand For Cell & Gene Therapy Commercialization
8/4/2025
08/04/25 Outsourced Pharma Newsletter
-
08.04.25 -- STREAM Edition: Here's Where CDMOs Improve For Cell And Gene Therapy Customers?
8/4/2025
08/04/25 Outsourced Pharma Newsletter
-
08.04.25 -- Relationship Equity With CDMOs Is Real, Take It From A Packaging Pro
8/4/2025
08/04/25 Outsourced Pharma Newsletter
-
08.01.25 -- Meeting The Demand For Bioanalytical Services
8/1/2025
08/01/25 Outsourced Pharma Newsletter
-
08.01.25 -- Biopharma Needs A Boost — Our Newest Podcast Has Ideas
8/1/2025
08/01/25 Outsourced Pharma Newsletter
-
08.01.25 -- CDMOs Should Stop Stringing Biotechs Along
8/1/2025
08/01/25 Outsourced Pharma Newsletter
-
07.31.25 -- Nitrosamine Impurity Detection And Quantification In Sartans And Ranitidine
7/31/2025
07/31/25 Outsourced Pharma Newsletter